Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

NCT00217438

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Rochester Rochester, New York, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma

NCT01085214

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

NCT02221479

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 392105 Kamogawa-Shi, Japan
  • Investigational Site Number 392103 Kyoto, Japan
  • Investigational Site Number 392102 Nagoya, Japan
  • Investigational Site Number 392104 Okayama, Japan
View Trial Details
Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +14 more
Locations
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHU de Nancy Nancy, France
  • Service de Médecine Interne - CHU de Saint Etienne Saint-Etienne, France
  • Service de rhumatologie - CHU de Saint Etienne Saint-Etienne, France
View Trial Details
Completed

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

NCT00131261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • James Berenson, MD, Inc West Hollywood, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Research Facility New York, United States
View Trial Details

Related conditions